Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00034008 · ClinicalTrials.gov registry record · Phase 2

Efficacy of Healing Touch in Stressed Neonates

A Phase 2 study of Stress, sponsored by National Center for Complementary and Integrative Health (NCCIH).

Completed
Registry status
Phase 2
Development phase
13
Enrollment target
1
Study location

NCT00034008: Completed Phase 2 study of Stress, sponsored by National Center for Complementary and Integrative Health (NCCIH).

NCT00034008 is a Phase 2 study of Stress that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 13 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00034008, a Phase 2 study of Stress, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).

COMPLETED
Registry status
Phase 2
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

The purpose of this project is to evaluate whether or not Healing Touch therapy (HT) helps to treat the stress of babies in the Neonatal Intensive Care Unit (NICU). Healing Touch is a gentle use of human touch - a light, soft placement without moving of the HT therapist's hand on a baby's body - and energy to create balance and relaxation. The goal of HT treatment is to help babies rest better, have less pain and discomfort and to heal more quickly. Healing Touch works along with all the treatments and medicines babies receive as part of ordinary care in the NICU.

Conditions Studied

Interventions

  • BEHAVIORAL Healing Touch

Study Locations (1)

Arizona

  • University of Arizona, University Medical Center, Neonatal Intensive Care Unit - Tucson

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2003-07
Est. Completion 2004-07
Phase Phase 2

What the finished NCT00034008 record still lists

NCT00034008 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Stress appearing as the primary indexed condition, and to 1 intervention - of which Healing Touch is the first listed.

NCT00034008 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT00034008 about?

NCT00034008 is a clinical study titled "Efficacy of Healing Touch in Stressed Neonates". The purpose of this project is to evaluate whether or not Healing Touch therapy (HT) helps to treat the stress of babies in the Neonatal Intensive Care Unit (NICU). Healing Touch is a gentle use of human touch - a light, soft placement without moving of the HT therapist's hand on a baby's body - and...

What is the current status of trial NCT00034008?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2003-07. Estimated completion is 2004-07.

What conditions does trial NCT00034008 study?

This clinical trial studies the following conditions: Stress.

What interventions are being tested in trial NCT00034008?

The interventions under investigation include: Healing Touch (BEHAVIORAL).

Who is sponsoring clinical trial NCT00034008?

This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00034008 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00034008's enrollment target sits among peer trials

13 148th of 152 higher than 4 of 152 other Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00034008, the US trial registry maintained by the National Library of Medicine. NCT00034008 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.